A single-center experience in open and endovascular treatment of hemodynamically unstable and stable patients with ruptured abdominal aortic aneurysms  by Coppi, Gioacchino et al.
CLINICAL RESEARCH STUDIES
A single-center experience in open and
endovascular treatment of hemodynamically
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Gioacchino Coppi, MD, Roberto Silingardi, MD, Stefano Gennai, MD, Giuseppe Saitta, MD, and
Anna Vittoria Ciardullo, MD, Modena, Italy
Objective: To retrospectively compare a single center’s immediate and mid-term outcomes of ruptured abdominal aortic
aneurysm open and endovascular repair (EVAR) for two patient groups—hemodynamically stable and unstable
patients—in the same time period.
Methods: Patients presenting at our center with confirmed rupture of an abdominal aortic aneurysm between December
1999 and April 2006 were considered according to an intention-to-treat model with EVAR. Patients with symptomatic
or acute (but not ruptured) AAAs were not included in this study. Thirty-three patients underwent EVAR, and 91
underwent open repair. Seventy-two patients (EVAR, 45%; open, 63%) were classified as hemodynamically unstable at
arrival, and 52 were classified as stable (EVAR, 55%; open, 37%). Ninety-seven percent of EVAR procedures commenced
under local anesthesia, and 100% of open repairs occurred with general anesthesia. Overall successful graft deployment,
30-day mortality, overall reintervention rate, and complications were the study primary end points.
Results: Overall successful graft deployment for EVAR was 91%; for open repair, it was 96%. Overall 30-day mortality for
EVAR was 30% (unstable, 53%; stable, 11%), and the rate was 46% for open repair (unstable, 61%; stable, 21%). The
EVAR postoperative reintervention rate (within 30 days) was 15% (unstable, 20%; stable, 11%), and for open repair it was
10% (unstable, 9%; stable, 15%). We recorded a 27% severe complication rate for EVAR patients (unstable, 40%; stable,
17%), and for patients treated with open repair, it was 33% (unstable, 35%; stable, 29%). Our overall EVAR eligibility rate
was 52%, and our overall EVAR treatment rate was 27%.
Conclusions: Our study’s overall results for EVAR remain encouraging when compared with those of conventional repair,
but large randomized trials are required to confirm the efficacy of the procedure. (J Vasc Surg 2006;44:1140-7.)The overall mortality rate for patients undergoing con-
ventional repair of ruptured abdominal aortic aneurysms
(rAAA) is up to 50%.1-5 Despite a documented gradual
decrease in this mortality rate in a 50-year meta-analysis,1 it
is generally accepted that there has been no consistent
improvement in the number of operative deaths associated
with rAAA in the last few decades.6 Conventional repair has
inherent limitations, including general anesthesia and lap-
arotomy.3,7-11 The advantages of endovascular repair
(EVAR) include the avoidance of both general anesthesia
and laparotomy, thus improving the physiological stress of
the procedure for the patient.12-22 EVAR itself also carries
with it an inherent limitation: a delay of treatment due to
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1140necessary preoperative imaging. However, recent studies
assessing the delay from patient arrival to death in nonsur-
gical groups conclude that it is safe to assess the majority of
rAAA for EVAR.23,24
Improvements in mortality and morbidity associated
with EVAR with respect to conventional repair have been
shown in some recent studies. However, these studies often
include symptomatic, nonruptured aneurysms together
with truly ruptured aneurysms, and most include a mix of
stable and unstable patients.13,17,18,20,25-30 We present our
study as a comparison of the efficacy of EVAR compared
with open repair for stable and unstable patients treated for
rAAA in our center in the same study period.
METHODS
A total of 124 consecutive patients presented at our
hospital during the study period (December 1999 to April
2006) with rAAA. Patients with acute or symptomatic but
intact aneurysms shown at computed tomography (CT)
were excluded. The exclusion criteria guidelines in our
center for EVAR are based on anatomic parameters: prox-
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greater than 32 mm, and external iliac artery diameter less
than 7 mm and severe bilateral iliac artery disease. Thirty-
three of the 124 patients were treated with EVAR. Thirty-
one of the 91 surgically treated patients would have been
anatomically suitable for EVAR but were treated with open
repair at the beginning of our experience: 6 patients due to
young age (initially considered a criteria of exclusion) and
25 patients due to unavailability of adequately trained staff
and endovascular supplies. Our overall EVAR eligibility
rate was 52% (64/124), and our overall EVAR treatment
rate was 27% (33/124). The outcomes measured included
immediate technical success (successful deployment of the
graft with complete sealing of the aneurysm), conversion,
immediate mortality (within 24 hours) and 30-day mortal-
ity, complications, reinterventions, mortality during pa-
tient follow-up, and intensive care unit (ICU) and hospital
stay.
We compared different rates in study outcomes be-
tween the groups by means of logistic regression analysis.
The level of significance was P  .05. Stata for Windows
(release 7.0) (StataCorp LP; College Station, Tex) statisti-
cal software package was used.
The patient demographic data are displayed in Table I.
These patients were categorized into two subgroups for
comparative analysis according to their presentation at the
hospital as being hemodynamically unstable (defined as
unconscious and/or with a systolic blood pressure 80
mmHg after fluid resuscitation) or hemodynamically stable
(conscious and/or with a systolic blood pressure 80 mm
Hg, with or without fluid resuscitation). Nineteen (58%) of
the EVAR patients were preoperatively classified as unfit for
surgical treatment because of advanced age and comorbidi-
ties.
All patients were assisted by a vascular surgeon and an
anesthesiologist from their presentation at the emergency
department through to the operating room. Permissive
hypotension was practiced with prudent fluid resuscitation
to keep systolic blood pressure around 80mmHg, to avoid
a recommencement of or increase in bleeding. Eighty-four
percent (EVAR, 88%; open, 83%) of patients were assessed
by contrast-enhanced spiral CT 5-mm slices of the abdo-
men. Rupture with CT was defined as extravasation of
blood surrounding the aneurysm, as evident by the scan. In
4 EVAR cases (12%) rupture was confirmed by intraopera-
tive angiography and intravascular ultrasonography (IVUS)
and in 16 open cases (18%) rupture was confirmed in the
operating room. During the CT scanning, the operating
room was prepared to further reduce delay.
The patients’ anatomic suitability for emergency EVAR
was also determined at CT. Five EVAR and 12 open cases
were transferred from other hospitals with previously per-
formed CT scans (delivered via a Dicon (Dicon; Kyonggi-
do, Korea) intranet system for evaluation during patient
transportation). The maximum time taken to execute the
CT was between 5 and 7minutes (total time delay of 15-20
minutes). The diameter and length of the aneurysms were
evaluated directly by the vascular surgeon from the screen.Open repair was performed in the traditional fashion, as
described in literature,31-33 with supraceliac clamping in
100% of the unstable patients and in 73% of the stable
patients. All grafts used in the study were commercially
available, supplied by Bard Inc (Murray Hill, New Jersey)
and Boston Scientific (Watertown, Mass).
Four of the 15 EVAR hemodynamically unstable pa-
tients followed a different course. These patients presented
unconscious with severe hypotension (40-50 mm Hg) and
were transferred directly to the operating room without
CT. Intraoperative angiography and IVUS allowed confir-
mation of the rupture and evaluation of EVAR suitability.
In these four patients, a prototype occlusion balloon, in-
serted from the contralateral femoral artery, was success-
fully used. This device, developed in collaboration with
Edwards Lifesciences (Irvine, Calif), is similar to a cali-
brated catheter of 14F with a double channel (for balloon
inflation and execution of intraoperative angiography).
Once the balloon was inflated in the suprarenal aorta, an
immediate increase in blood pressure was observed in all
four patients. The endograft was then successfully posi-
tioned, and the occlusion balloon was deflated and with-
drawn.
All EVAR procedures were performed in a dedicated
Table I. Summary of patient demographics,
comorbidities, and preoperative aneurysm anatomic
features
Variable EVAR Open
Median age, y (range) 81 (65-99) 77 (53-92)
Sex (M/F) 28/5 74/17
Unstable 15 57
Stable 18 34
ASA class
III 49% 52%
IV 19% 28%
V 32% 20%
Comorbidities
Diabetes 18% 11%
Smoker 24% 54%
Hypertension 87% 73%
Hyperlipidemia 33% 35%
Cardiac disease 69% 55%
Carotid disease 3% 5%
Renal disease 6% 15%
Respiratory disease 69% 30%
Previous laparotomy 25% 8%
Obesity 40% 30%
Patient unfit for AAA open repair 19 (64%) —
Patient unfit for general
anesthesia
13 (43%) —
AAA maximum diameter (mm),
median (range)
70 (43-100) 75 (60-100)
Neck diameter (mm),
median (range)
23 (20-30) 27 (24-30)
Neck length (mm),
median (range)
26 (14-40) 13 (0-28)
EVAR, Endovascular aneurysm repair; ASA, American Society of Anesthe-
siologists; AAA, abdominal aortic aneurysm repair.vascular operating room equipped with mobile C-arm
t.
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IVUS (Volcano s5; Volcano Corporation; Rancho Cor-
dova, Calif), and ecoduplex scanner (Esaote AU 5; Socrate
Medical Srl, Cesano Boscone, Milan, Italy). Our EVAR
team includes two vascular surgeons (at least one endovas-
cular expert), an anesthesiologist, an endovascular-trained
operating room nurse, and a radiologic technician.
Ninety-seven percent of the EVAR procedures com-
menced under local anesthesia (1% lidocaine) accompanied
when required with intravenous sedation for pain relief and
patient immobility. Arterial access was obtained through
surgical exposure of both femoral arteries, except in one
case (Powerlink bifurcated endograft; Endologix Inc, Ir-
vine, Calif), for which it was obtained through the exposure
of the right artery and percutaneous access through the left
femoral artery. Intraoperative angiography was performed
manually through a 7F or 8F 45-cm introducer sheath
(Cordis; Cordis Corp; Hialeah, Fla) inserted from the
femoral artery contralateral to the side chosen for the
deployment of the endograft. A 9F 55-cm introducer
sheath (Cordis; Cordis Corp; Hialeah, Fla) was used when
IVUS was performed. With angiography, the exact posi-
tions of the renal arteries and the aortic bifurcation were
determined and marked directly by the vascular surgeon on
the C-arm screen.
After the insertion of a super-stiff guidewire (Am-
Table II. Operative details
Variable
Product
Zenith
Talent
Powerlink
Excluder
Endologix
Hemashield Gold
Bard
Total
Imaging Assessment
CT
Stable
Unstable
Intraoperative IVUS/angiography (without preoperative CT)
Stable
Unstable
Procedural time, min, median (range)
Duration skin to skin
AUI
Bifurcated
Tube
Anesthesia
Local
Local to general
Epidural
General
Volume of contrast agent, mL, median (range)
EVAR, Endovascular aneurysm repair; Bif, bifurcated endograft; AUI, aor
intravascular ultrasonography.
*Four patients died during the intervention, before deployment of the grafplatz or Backup Meyer; Boston Scientific), the endograftwas deployed. The aortouni-iliac device (AUI) coupled
with a femorofemoral bypass was the preferred technique
in rAAA (73%). Completion angiography confirmed ad-
equate proximal and distal fixation and identified any
endoleak. In the case of an AUI procedure, a contralat-
eral plug was inserted, and the procedure was completed
with a crossover femorofemoral bypass with a polytetra-
fluoroethylene graft. Most patients undergoing this pro-
cedure were converted to general anesthesia, but in seven
patients the entire procedure was completed with local
anesthesia. When required, postdilation was executed
with a compliant balloon (Reliant; Medtronic, World
Medical Manufacturing Corp, Sunrise, Fla).
All of the endografts used in the study were commer-
cially available: Talent (Medtronic Vascular, Santa Rosa,
Calif), Excluder (W. L. Gore and Associates, Flagstaff,
Ariz), Zenith (Cook, Bloomington, Ind), and Powerlink.
The endografts were chosen according to the aneurysms’
anatomic characteristics.
From the end of 2003, Cook has supplied our center
with a specialized emergency kit of AUI Zenith endografts
with proximal diameters of 24, 28, and 32 mm; a distal
diameter of 12 mm; and a fixed 122-mm length. When
necessary, the AUI graft can be lengthened with commer-
cially available distal extensions.
The EVAR follow-up scheme consisted of routine CT
EVAR Open
13 (1 Bif, 12 AUI) —
12 (1 Bif, 11 AUI) —
3 (1 Bif, 1 AUI, 1 Tube) —
4 (4 Bif) —
1 (1 Tube) —
— 77 (63 Tube, 14 Bif)
10 (9 Tube, 1 Bif)
33 87*
18 (100%) 34 (100%)
11 (73%) 41 (72%)
0 0
4 (27%) 0
133 (60-510) 178 (60-600)
139 (60-510) —
111 (60-180) 247 (100-600)
60 171 (60-360)
11 (45%) 0
19 (52%) 0
1 (3%) 0
0 91 (100%)
201 (20-600) —
iliac endograft; Tube, Tube endograft; CT, computed tomography; IVUS,touni-before discharge, at 3 and 12 months, and annually there-
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months and annually thereafter. Plain radiographs were
performed before discharge, at 6 months, and annually
thereafter. Open follow-up consisted of an ecoduplex scan
at 1 month and the second and fifth years.
RESULTS
Operative data are displayed in Table II. The proce-
dural details illustrate less invasiveness by the EVAR proce-
dure, with a reduced overall procedure duration and in-
creased use of local anesthesia. The EVAR study results are
presented in Table III. The four perioperative deaths were
caused by intractable hypovolemic shock. Within the first
24 hours, three further deaths occurred: two from multiple
organ failure and one from bowel infarction. A further
patient died 12 days after the procedure from multiple
organ failure. Both immediate and 30-day mortality were
statistically significant between the two groups (P  .01).
Three patients were immediately converted to open
surgery. One conversion was due to the technical inability
to successfully insert the AUI Talent endograft in a tortu-
ous anatomy. A second conversion was performed because
the device could not be attached to the short neck (AUI
Talent). Furthermore, a proximal cuff could not be inserted
to correct this error because of the bending of the endograft
in the aneurysmal sac, thus impeding its passage. An aorto-
bifemoral bypass was performed in both cases. Both of
these patients died during surgery as a result of intractable
hypovolemic shock. The final immediate conversion was
also performed because an AUI Talent endograft could not
be attached to the short, proximal neck; this resulted in a
Table III. Results of endovascular treatment
Variable Overal
No. patients in study 33
Immediate conversion 9% (3/33)
Successful graft deployment 91% (30/33)
Immediate mortality (within 24 h) 27% (9/33)
30-d mortality 30% (10/33)
Conversion at a distance 3% (1/30)
Overall reintervention rate 23% (7 in 6 p
Postoperative reintervention (within 30 d) 15% (5/33)
Secondary intervention 6% (2/33)
Severe systemic complications 27% (9/33)
MOF (fatal) 3
Bowel infarction (fatal) 1
ACS 1*
Acute renal failure (dialysis) 1*
Stroke 1
Severe respiratory insufficiency 1†
Gastrointestinal bleeding 1†
ICU stay
No. patients 14
Average, h (range) 64
Hospital stay, d, median (range) 13 (1-30)
NS, Not statistically significant; MOF, multiple organ failure; ACS, abdomi
*Same patient.
†Same patient.proximal endoleak that remained despite an attemptedcorrection. A surgical aortoaortic interposition was then
performed successfully.
Of the 26 patients who survived successful endovascu-
lar treatment, 14 (54%) were transferred to the ICU. There
were five (17%) incidents of postoperative systemic compli-
cations in three patients which were not associated with
fatal outcomes. One patient developed abdominal com-
partment syndrome and underwent drainage of the hema-
toma by an extraperitoneal approach through a left iliac
fossa cutdown. This situation was complicated further with
acute renal failure necessitating dialysis, although the com-
pletion angiography showed patency of both renal arteries.
One patient had a stroke, and another patient experienced
respiratory insufficiency accompanied by gastrointestinal
bleeding and was treated with medication only.
We experienced five (17%) postoperative reinterven-
tions. One patient developed a complete thrombosis of the
AUI Talent endograft which was treated with an extra-
anatomic axillobifemoral bypass. One patient developed a
thrombosis of the crossover and a type III endoleak be-
tween the two segments of the AUI Talent endograft. This
patient was treated with an additional segment of en-
dograft, and the crossover was redone. A third patient
developed a type I proximal endoleak (AUI Zenith), which
was considered unsuitable for correction by the addition of
a proximal cuff because of the shortness of the aneurysmal
neck. Therefore, through a small abdominal incision, a
Dacron band (DuPont, Wilmington, Del) was successfully
placed around the proximal neck to reduce the diameter
and obtain complete sealing. Another patient developed a
type I distal endoleak (AUI Zenith) because of an incom-
Unstable Stable P value
15 18
2 1 NS
87% (13/15) 94% (17/18) NS
46% (7/15) 11% (2/18) .01
53% (8/15) 11% (2/18) .01
1 —
s) 20% (3/15) 17% (3/18) NS
20% (3/15) 11% (2/18) NS
11% (2/18) —
40% (6/15) 17% (3/18) NS
3 —
1 —
1* —
1* —
1 —
1† —
1† —
7 6 NS
107 (10-280) 25 (4-48) .01
15 (7-24) 9 (1-30) .01
mpartment syndrome; ICU, intensive care unit.l
atient
nal coplete sealing by the plug. A larger plug was inserted to
nal co
, mul
for op
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endoleak (AUI Talent), which was treated with a 25-mm
balloon dilation of the proximal neck attachment, with a
reduction, but not the complete exclusion, of the aneu-
rysm. Given the modest entity of the endoleak, the hemo-
dynamic stability, and the stability of the dimension of the
hematoma at the postoperative CT, the patient was main-
tained under observation.
Two secondary interventions were necessary during the
follow-up period. At 1 year, a new type I distal endoleak was
successfully treated with a distal extension. At 6 months,
the patient who had previously been unsuccessfully treated
with a balloon dilation in the postoperative period was
converted after a further unsuccessful attempt at endovas-
cular correction with a proximal cuff extension. Our overall
incidence of endoleak was 17% (5/30), and 4 of the 5
occurrences were primary endoleaks.
At a mean follow-up of 27.5 months (range, 30-1456
days), we have recorded five patient deaths. Two patients
Table IV. Results of open repair
Variable Overall
No. patients in study 91
Immediate mortality (within 24 h) 31% (28/91
30-d mortality 46% (42/91
Postoperative reintervention (within 30 d) 10% (9/91)
Severe systemic complications 33% (30/91
MOF (fatal) 10
Bowel infarction 8 (6 fatal
ACS 1
Acute renal failure (dialysis) 4
Stroke 1
Severe respiratory insufficiency 5
Gastrointestinal bleeding 1
No. patients 87
ICU stay, h, median (range) 120 (48-88
Hospital stay, d, median (range) 14 (2-42)
NS, Not statistically significant; MOF, multiple organ failure; ACS, abdomi
Table V. EVAR compared with open surgery for stable an
Variable
U
EVAR
No. patients 45% (15/33) 6
30-d mortality 53% (8/15) 6
Postoperative reintervention (within 30 d) 20% (3/15)
Systemic complications 40% (6/15) 3
MOF (fatal) 3
Bowel infarction 0
ACS 1
Acute renal failure 1
Stroke 1
Severe respiratory insufficiency 0
Gastrointestinal bleeding 0
ICU stay, h, median (range) 48 (10-280)
Hospital stay, d (mean  SD) 15.1  6.6
EVAR, Endovascular aneurysm repair; NS, not statistically significant; MOF
Overall mortality at 30 days was 30% (10/33) for EVAR and 46% (42/91)died 3 months after the intervention; one patient from thestable group experienced bowel infarction, and another
patient from the unstable group died from a myocardial
infarction. At 6 months, a third patient from the unstable
group died from congestive heart failure. At the 1-year
follow-up, two further deaths were recorded in the stable
group (from a stroke and a bowel infarction).
Table IV reports the results of the open repair, which
compare to the results of other open repair studies.31-33
Table V compares the 30-day outcomes between the
EVAR and open groups. The comparison of the mortal-
ity rates shows a lower rate for EVAR both in the stable
and unstable groups (no statistical significance). Com-
paratively, the reintervention rate within 30 days was
relatively higher for EVAR than for open repair (no
statistical significance).
As shown in the Figure, the cumulative survival prob-
ability for EVAR at 1 year is 49% (Kaplan-Meier curve).
However, a significant difference can be observed between
Unstable Stable P value
57 34
46% (26/57) 6% (2/34) .01
61% (35/57) 21% (7/34) .01
9% (5/57) 15% (4/34) NS
35% (20/57) 29% (10/34) NS
8 2 —
5 (4 fatal) 3 (2 fatal) —
1 —
2 2 —
1 —
2 3 —
1 —
53 34 NS
144 (48-888) 96 (48-888) NS
12 (2-37) 10 (2-42) NS
mpartment syndrome; ICU, intensive care unit.
stable patient groups
le Stable
pen P value EVAR Open P value
57/91) NS 55% (18/33) 37% (34/91) NS
35/57) NS 11% (2/18) 21% (7/34) NS
5/57) NS 11% (2/18) 15% (4/34) NS
20/57) NS 17% (3/18) 29% (10/34) NS
9 — 0 2 —
4 fatal) — 1 (fatal) 3 (2 fatal) —
0 — 0 0 —
3 — 0 2 —
1 — 0 0 —
2 — 1 3 —
1 — 1 0 —
48-888) NS 24 (4-48) 96 (48-888) .05
 9.4 .01 8.8  7.3 14.1  9.6 NS
tiple organ failure; ACS, abdominal compartment syndrome.
en procedures (NS).)
)
)
)
8)d un
nstab
O
3% (
1% (
9% (
5% (
5 (
144 (
14.1the two subgroups (P  .01).
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Both open repair and EVAR for rAAA in the literature
have results that are difficult to interpret because often
patients with symptomatic but not ruptured aneurysms are
included, and the hemodynamic situations are not consid-
ered in relation to the outcome (Table VI). In our study, we
included only patients with evidenced rupture. They were
divided into two groups based on their hemodynamic
condition in the period from arrival to intervention. This
classification of the two patient groups was developed to
discern whether there was a difference in terms of outcome.
The definition of patients’ hemodynamic stability was dif-
ficult. The main criterion we chose, as is common in other
studies, was the blood pressure at observation. We used a
cutoff of 80 mm Hg. It is clear that the arterial pressure
cannot alone be sufficient to give a true indication of the
gravity of the individual patient’s condition, which often
also depends on the amount of bleeding and the patient’s
general condition before rupture of the aneurysm. The
varying definitions render a comparison of the various
studies difficult. Thus, a development of a consensus be-
tween experts is required to establish which patients will
benefit from EVAR in comparison to open repair and
whether, in some situations, abstention is indeed better
than surgical or endovascular treatment.34
A crucial point to consider when treating with EVAR is
the time delay linked to the necessary CT scan, particularly
in hemodynamically unstable patients. In our center, the
Fig. Cumulative survival after endovascular repair of r
curve).time delay for a CT scan has been reduced to approximately15 to 20 minutes, in line with other specialized cen-
ters.16,29,35 In reality, the survival of patients arriving alive
in the hospital with rAAA is longer than one usually be-
lieves. Lloyd et al23 reported a survival longer than 2 hours
in 87.5% of untreated rAAA patients and a median time
from the beginning of symptoms to death of more than 16
hours. Furthermore, Walker et al36 reported a mean time
interval between admission and death of 8 hours. In our
experience, four EVAR patients who presented in a state of
shock (with blood pressure 50 mm Hg) underwent a
simple ecoduplex scan and were then transported immedi-
ately to the operating room without CT. However, except
for extreme and selected cases, the CT scan remains our
first-choice imaging assessment for rAAA because it offers a
sure diagnosis of rupture, showing the periaortic hema-
toma; it supplies vital information about the arterial ac-
cesses and the aneurysmatic morphology and, hence, per-
mits rapid evaluation of endovascular feasibility.
In these same four EVAR patients, we used a proto-
type occlusion balloon, which proved extremely useful.
In general, the aortic occlusion balloon represents a
theoretical advantage because it mimics surgical clamp-
ing and immediately slows the hemorrhage. However,
dedicated occlusion balloons are not available on the
market, and the use of nondedicated balloons is prob-
lematic, primarily because of balloon instability and di-
ameter, the flexibility of the catheters, and problems
linked to executing angiography appropriately.37 For all
ed abdominal aortic aneurysms (Kaplan-Meier survivalupturof these issues, we believe that, today, the rapid deploy-
were
cified.
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ception of gravely unstable patients.37
In EVAR treatment, we developed a preference for the
AUI endograft (used in 73% of cases) given its simple and
rapid deployment and greater anatomic adaptability. Our
preference is not supported on the whole by other studies,
which collectively have a mean use of AUI of 46.2% (Table
VI).
EVAR has a higher reintervention rate than open repair
(Table V). This could be attributed to the great dimensions
and difficult anatomies of these patients selected for EVAR,
especially in terms of tortuosity and shortness of the aneu-
rysmatic neck, and the necessary rapidity of the procedure.
The principal studies of EVAR for rAAA (Table VI)
report a mean mortality rate of 21% (varying from 9.5% to
45%), which is significantly lower than the historical mor-
tality rates associated with surgery.31-33 However, there are
very few published experiences of EVAR for rAAA, and
these also have limited patient numbers (few studies have
25 patients). Furthermore, the mean percentage of pa-
tients treated who are hemodynamically unstable and,
therefore, at higher risk is infrequently specified, but our
literature review shows it to be 32%.4,14-16,18,19,21,25-30
Although the combined mortality rates of 30% for
EVAR and 46% for the surgically treated group (Table V)
are not statistically significant, these results encourage us to
continue our intention to treat with EVAR at our institu-
tion. However, our limited experience is not evidence that
EVAR should be considered the first-choice treatment for
rAAA. Whether EVAR should be considered a preferable
Table VI. Series of emergency endovascular repair of rAA
Study (location) Period No. P
Ohki, Veith, and associates
(Montefiore)25,26
1994-1999 20
Hinchliffe (Nottingham)14 1994-2000 20 
Scharrer-Pamler (Ulm)18 1995-2001 24 
Resch (Malmo)19 1997-2002 21 
van Heerzeele (Ghent)21 1997-2002 9 
Hechelhammer (Zurich)27† 1997-2003 37 
Lachat (Zurich) 16† 1998-2001 21 
Gerassimidis (Thessaloniki)4 1998-2004 23 
Yilmaz (Eindhoven)15‡ 1999-2001 24 (17
Alsac (Créteil)28 2001-2004 17 
Larzon (Sweden) 29 2001-2004 15 
Peppelenbosch (Belgium/Netherlands)30 2001-2004 35 
Lee (Florida) 31§ 2002-2004 13 
Total/average 279
rAAA, Ruptured abdominal aortic aneurysm; AUI, aortouni-iliac endograf
combination of different, unspecified grafts.
*Thirty-day mortality is given where possible.
†Same partial patient cohort; the Hechelhammer series was a more recent a
‡The Eindhoven study also contained symptomatic and acute patients with
§Unspecified percentage of hemodynamically unstable patients; no patients
The Florida study was not included, in which unstable patients were unspeoption for stable or unstable patients remains unknown.Our experience shows a greater advantage for EVAR in
stable patients in terms of mortality, morbidity, and ICU
stay, and this is quite surprising given that it would have
been logical to hypothesize that the patients in the most
critical condition (unstable) would be those who would
benefit most from a less invasive approach.
An explanation of the similar mortality for EVAR and
open treatment in the unstable group could be that the
grave condition of the patient at presentation is the deter-
mining factor for survival, rather than the type of interven-
tion chosen. The relatively higher mortality rate for the
stable open group when compared with the stable EVAR
group could be explained by the fact that the high invasive-
ness of the surgical treatment could precipitate the patients
from a stable condition to an unstable one, thereby wors-
ening their chances of survival.
The improvements of the diagnostic/therapeutic
course and of the availability of materials seem to have
positively conditioned the results, but further improve-
ments seem possible, such as dedicated kits that render the
procedure more rapid and simple. Certainly, randomized
trials are mandatory to establish the real efficacy of EVAR
for rAAA.
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dinate the data collection, analysis, and writing of the
article.
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